SEBI-Approved 5 IPOs From Diverse Segments
- By Kotak News Desk
- 17 Feb 2026 at 2:36 PM IST
- Market News
- 4m
SEBI has greenlit five diverse companies, including Duroflex and Virupaksha Organics, to launch their IPOs. Spanning the consumer, pharmaceutical, and industrial sectors, these approvals signal a busy primary market. Read ahead to know more.
The Securities and Exchange Board of India (SEBI) has greenlit IPOs of five companies. These companies include Duroflex, Virupaksha Organics, Hexagon Nutrition, Premier Industrial Corporation, and Om Power Transmission.
The companies received the regulator’s “observations” between 10 February and 13 February, which effectively clears the way for them to proceed with their Initial Public Offerings (IPOs).
The five diverse companies represent a healthy mix of the Indian economy. These businesses cover everything from the mattresses we sleep on to the micronutrients in our food and the power lines that light our homes.
These filings were mostly submitted in late 2025. Now, they have cleared the regulatory hurdles and have received a one-year window to list on exchanges.
The important question for the investors is: are you prepared to navigate this wave of upcoming public issues as the market appetite for mid-cap stories remains robust?
IPO Details Of The Five Companies
Here are the brief details about the five companies that have received the SEBI nod:
Duroflex
Duroflex is a household name in the "sleep solutions" space. The company is looking to utilise its IPO proceeds to considerably expand its market presence through its Company-Owned Company-Operated (COCO) stores. COCO stores are different from traditional dealerships and are flagship outlets managed directly by the brand.
Duroflex plans to set up new COCO stores for direct retail and high-margin "sleep-tech" products. Here is a table summarising the issue.
Issue Type | Fresh Issue + Offer for Sale (OFS) |
Fresh Issue Size | ₹183.6 Cr. |
Offer for Sale | 2.25 Cr. Equity Shares |
Primary Use of Funds | 120 new COCO stores, Marketing, debt repayment |
Main Business | Mattresses, Pillows, and Sleep-tech |
Virupaksha Organics
Virupaksha Organics, a Telangana-based pharmaceutical company, has opted for an entirely fresh issue. The IPO funds are earmarked for capacity expansion and debt repayment. By reducing debt, the company might be able to improve the "bottom line." Also, since it is a research-driven pharma firm, having a clean balance sheet can help it to more aggressively invest in R&D and new manufacturing lines.
Issue Type | 100% Fresh Issue |
Total Value | ₹740 Cr. |
Primary Use of Funds | Capacity expansion and debt repayment |
Main Business | Research driven pharma and application programming interfaces (APIs) |
Hexagon Nutrition
Hexagon Nutrition had previously received approval for its IPO years ago (in 2022), but it chose not to list. Now, they are back with a pure OFS. This company manufactures micronutrient premixes. Since it is a pure OFS, the founding family is passing the ownership to public shareholders.
Issue Type | 100% OFS |
Total Shares | 3.08 Cr. Equity Shares |
Primary Use of Funds | Providing promoters exit to the Kelkar Family and existing investors |
Main Business | Micronutrient premixes and clinical nutrition |
Premier Industrial Corporation
Premier Industrial operates in the welding segment, focusing on the production and supply of welding consumables and related raw materials. Welding consumables is a sector that thrives when infrastructure and manufacturing are booming. The total issue size of the IPO is 2.79 Cr shares. The fresh issue IPO funds are planned to be used for building new facilities in Raigad.
Issue Type | Fresh Issue + Offer for Sale (OFS) |
Fresh Issue Portion | 2.25 Cr. Equity Shares |
Offer For Sale | 54 lakh shares |
Primary Use of Funds | New manufacturing facility at Raigad and Wada unit expansion |
Main Business | Welding consumables (powders and wires) |
Om Power Transmission
Om Power Transmission operates in the EPC (Engineering, Procurement, and Construction) segment. The total issue size of the IPO is 1 Cr. equity shares.
Issue Type | Fresh Issue + Offer for Sale (OFS) |
Fresh Issue Portion | 90 lakh shares |
Offer For Sale | 10 lakh shares |
Primary Use of Funds | Purchase of equipment, repayment of debt and promoter liquidation |
Core Business | Power Transmission engineering, procurement and construction (EPC) |
These companies form a core part of India’s industrial ecosystem. Their decision to list suggests that the momentum under the Make in India programme is beginning to translate into visible progress.
Investor Takeaways
The approval of these five companies could indicate that SEBI is clearing the path for a very diverse listing season. Whether you are a fan of "defensive" sectors like pharma and nutrition or "cyclical" sectors like infrastructure and welding, the menu is becoming quite diversified.
As the companies proceed towards forming IPO announcement details, it would be interesting to know their listing timelines and view their post-listing performance.
Source:
Fortune India
Moneycontrol
India IPO
Since its incorporation on 20 July 1994, Kotak Neo has grown into one of India’s most trusted brokerage houses - backed by over 30 years of expertise across stocks, funds, IPOs, and full-service investing.
With a pan-India footprint of 145+ branches, 1000+ franchises and presence across 310+ cities, Kotak Neo serves 5 million+ customers nationwide.
From equities and IPOs to mutual funds and derivatives, Kotak offers comprehensive, research-backed investment solutions - simplifying wealth management for retail and institutional clients alike.
Kotak News Desk brings you latest updates, expert insights, and market-ready ideas - helping you stay informed and invest smarter.
Connect on: Linkedin
0 people liked this article.
